Abstract
Accelerated radiation therapy over three weeks is safe and effective for whole breast radiation therapy. The prone position improves normal tissue toxicity while maintaining target coverage. Based on our initial dosimetric studies, we implemented a prospective clinical trial to evaluate the feasibility and tolerability of prone accelerated intensity modulated radiation therapy (IMRT) to treat the breast, level III axilla, and supraclavicular lymph nodes in breast cancer patients who had undergone axillary dissection with involved lymph nodes.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Radiation Oncology*Biology*Physics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
